Foster-Cheek Kaye I
- SEC CIK
- 0001312622
No open-market purchases or sales filed in the past year.
Current role at each company
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- PRME Prime Medicine, Inc.Directoras of Jun 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Foster-Cheek Kaye I as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AGIO Agios Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 (view filing) | Mar 7 | 4 days | Foster-Cheek Kaye IDirector | SSale | −1.28K | $31.62 | −$40.6K | −18.9%5.52K after | |
| Mar 7, 2024 (view filing) | Mar 5-6 | 2 days | Foster-Cheek Kaye IDirector | SSale | −4.71K | $32.00 | −$150.9K | −40.9%6.81K after | 2 lots |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Foster-Cheek Kaye IDirector | SSale | −25.0K | $25.96 | −$649.0K | −68.4%11.5K after |